| 1 |
34871735 | In vivo susceptibility to energy failure parkinsonism and LRRK2 kinase activity. | 2022 Jan |
1 |
| 2 |
35016506 | Effect of Coffee against MPTP-Induced Motor Deficits and Neurodegeneration in Mice Via Regulating Gut Microbiota. | 2022 Jan 12 |
1 |
| 3 |
35622265 | Garcinia morella extract confers dopaminergic neuroprotection by mitigating mitochondrial dysfunctions and inflammation in mouse model of Parkinson's disease. | 2022 May 27 |
2 |
| 4 |
33972465 | The Pathological Role of Astrocytic MAOB in Parkinsonism Revealed by Genetic Ablation and Over-expression of MAOB. | 2021 Apr 30 |
2 |
| 5 |
34478811 | Dynamic changes of activated AHR in microglia and astrocytes in the substantia nigra-striatum system in an MPTP-induced Parkinson's disease mouse model. | 2021 Nov |
1 |
| 6 |
31430407 | Neuroprotection and immunomodulation of progesterone in the gut of a mouse model of Parkinson's disease. | 2020 Jan |
2 |
| 7 |
31653343 | Nei-like 1 inhibition results in motor dysfunction and promotes inflammation in Parkinson's disease mice model. | 2020 Jan 1 |
1 |
| 8 |
33062722 | Functional Crosstalk between CB and TRPV1 Receptors Protects Nigrostriatal Dopaminergic Neurons in the MPTP Model of Parkinson's Disease. | 2020 |
2 |
| 9 |
33519420 | A Comprehensive Phenotype of Non-motor Impairments and Distribution of Alpha-Synuclein Deposition in Parkinsonism-Induced Mice by a Combination Injection of MPTP and Probenecid. | 2020 |
1 |
| 10 |
30644041 | Tinospora cordifolia Suppresses Neuroinflammation in Parkinsonian Mouse Model. | 2019 Mar |
2 |
| 11 |
30728466 | NLRP3 inflammasome pathway is involved in olfactory bulb pathological alteration induced by MPTP. | 2019 Aug |
2 |
| 12 |
30928412 | Neutral sphingomyelinase increases and delocalizes in the absence of Toll-Like Receptor 4: A new insight for MPTP neurotoxicity. | 2019 Jun |
2 |
| 13 |
30477535 | Effect of NAC treatment and physical activity on neuroinflammation in subchronic Parkinsonism; is physical activity essential? | 2018 Nov 26 |
3 |
| 14 |
30559650 | Unexpected Exacerbation of Neuroinflammatory Response After a Combined Therapy in Old Parkinsonian Mice. | 2018 |
1 |
| 15 |
28192111 | Effects of progesterone administered after MPTP on dopaminergic neurons of male mice. | 2017 May 1 |
4 |
| 16 |
28982631 | Effect of the 5α-reductase enzyme inhibitor dutasteride in the brain of intact and parkinsonian mice. | 2017 Nov |
2 |
| 17 |
27182044 | MPTP neurotoxicity is highly concordant between the sexes among BXD recombinant inbred mouse strains. | 2016 Jul |
1 |
| 18 |
24687411 | MDMA administration during adolescence exacerbates MPTP-induced cognitive impairment and neuroinflammation in the hippocampus and prefrontal cortex. | 2014 Oct |
1 |
| 19 |
24995576 | CNB-001, a novel pyrazole derivative mitigates motor impairments associated with neurodegeneration via suppression of neuroinflammatory and apoptotic response in experimental Parkinson's disease mice. | 2014 Sep 5 |
1 |
| 20 |
25025494 | Early activation of STAT3 regulates reactive astrogliosis induced by diverse forms of neurotoxicity. | 2014 |
1 |
| 21 |
25087727 | RETRACTED: Neuroprotective and neurotrophic effects of Apigenin and Luteolin in MPTP induced parkinsonism in mice. | 2014 Nov |
1 |
| 22 |
23558233 | Systems analysis of genetic variation in MPTP neurotoxicity in mice. | 2013 Jul |
2 |
| 23 |
24223584 | Neuroprotective Properties of a Novel Non-Thiazoledinedione Partial PPAR- γ Agonist against MPTP. | 2013 |
1 |
| 24 |
24262283 | Asiaticoside, a trisaccaride triterpene induces biochemical and molecular variations in brain of mice with parkinsonism. | 2013 Nov 21 |
1 |
| 25 |
21324658 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neuroblastic apoptosis in the subventricular zone is caused by 1-methy-4-phenylpiridinium (MPP(+)) converted from MPTP through MAO-B. | 2012 Nov |
1 |
| 26 |
22912680 | Neuroprotective activities of palmitoylethanolamide in an animal model of Parkinson's disease. | 2012 |
1 |
| 27 |
21970803 | Preventive and therapeutic effects of caffeic acid against inflammatory injury in striatum of MPTP-treated mice. | 2011 Nov 30 |
2 |
| 28 |
20431930 | Biochemical alterations of the striatum in an MPTP-treated mouse model of Parkinson's disease. | 2010 Jun |
2 |
| 29 |
20576415 | S-allylcysteine reduces the MPTP-induced striatal cell damage via inhibition of pro-inflammatory cytokine tumor necrosis factor-α and inducible nitric oxide synthase expressions in mice. | 2010 Dec 15 |
1 |
| 30 |
21095732 | In vivo imaging of retinal gliosis: a platform for diagnosis of PD and Screening of anti-PD compounds. | 2010 |
2 |
| 31 |
19027004 | Role of nuclear transcription factor kappa B (NF-kappaB) for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine)-induced apoptosis in nigral neurons of mice. | 2009 Feb |
2 |
| 32 |
19196989 | Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: Critical role for the astrocyte. | 2009 Feb 24 |
1 |
| 33 |
19199078 | A novel anti-Parkinsonian agent, zonisamide, attenuates MPTP-induced neurotoxicity in mice. | 2009 Sep |
2 |
| 34 |
19318502 | Pyrethroid and organophosphate insecticide exposure in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease: an immunohistochemical analysis of tyrosine hydroxylase and glial fibrillary acidic protein in dorsolateral striatum. | 2009 Feb |
1 |
| 35 |
19631714 | Gender differences on MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in C57BL/6 mice. | 2009 Nov 13 |
1 |
| 36 |
19777158 | The impact of age and gender on the striatal astrocytes activation in murine model of Parkinson's disease. | 2009 Nov |
3 |
| 37 |
17963913 | Alteration in the differentiation-related molecular expression in the subventricular zone in a mouse model of Parkinson's disease. | 2008 Jan |
2 |
| 38 |
18030609 | Protective action of neuronal nitric oxide synthase inhibitor in the MPTP mouse model of Parkinson's disease. | 2008 Mar |
3 |
| 39 |
18235988 | Role of reactive nitrogen and reactive oxygen species against MPTP neurotoxicity in mice. | 2008 Jun |
5 |
| 40 |
18340525 | Proteasome inhibitor does not enhance MPTP neurotoxicity in mice. | 2008 Nov |
2 |
| 41 |
17439923 | Manganese does not alter the severe neurotoxicity of MPTP. | 2007 Mar |
2 |
| 42 |
17676428 | Damage to oligodendrocytes in the striatum after MPTP neurotoxicity in mice. | 2007 |
3 |
| 43 |
16581975 | Deficiency of TNF receptors suppresses microglial activation and alters the susceptibility of brain regions to MPTP-induced neurotoxicity: role of TNF-alpha. | 2006 Apr |
1 |
| 44 |
16736245 | Time dependent alterations of co-localization of S100beta and GFAP in the MPTP-treated mice. | 2006 Dec |
7 |
| 45 |
15159144 | Biochemical, behavioral and immunohistochemical alterations in MPTP-treated mouse model of Parkinson's disease. | 2004 May |
2 |
| 46 |
15327754 | Neuroprotective effect of the angiotensin-converting enzyme inhibitor perindopril in MPTP-treated mice. | 2004 Sep |
1 |
| 47 |
15519947 | Detection and semi-quantitative determination of low abundance GFAP mRNA in mouse brain by capillary electrophoresis coupled with laser-induced fluorescence. | 2004 Nov |
1 |
| 48 |
15567338 | Arundic acid, an astrocyte-modulating agent, protects dopaminergic neurons against MPTP neurotoxicity in mice. | 2004 Dec 24 |
1 |
| 49 |
12673835 | Expression of S-100 protein is related to neuronal damage in MPTP-treated mice. | 2003 May |
2 |
| 50 |
12822832 | Role of dopamine transporter against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in mice. | 2003 Jun |
1 |